US Health and Human Services' Thompson set for talks with AdvaMed:
This article was originally published in Clinica
US Health and Human Services Secretary Tommy Thompson will demonstrate his continued interest in the medical device industry this week when he meets with AdvaMed's board of directors on June 20. Mr Thompson has been an outspoken advocate for medical device user fees and his drive to unite his sprawling sinecure into one department is already fostering greater co-operation within its various powerhouse health agencies. At AdvaMed's recent Device Submission Workshop, there was repeated talk about the US FDA collaborating with the National Institutes of Health, with Medicare administrators and with the Centers for Disease Control and Prevention.
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.